Hemosiderin deposits surrounding the cerebral cavernous malformations (CCMs) had been proposed to be associated with the pathogenesis of CCM-related epilepsy (CRE). An increased perilesional and extralesional iron deposition were found in CCMs with epilepsy through susceptibility maps of quantitative susceptibility mapping (QSM). To investigate novel biomarkers for the in vivo and longitudinal evaluation of CCM lesions with epilepsy, this study was to explore the iron quantity in CCMs patients with CRE using quantitative susceptibility mapping.
This abstract and the presentation materials are available to members only; a login is required.